BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37652556)

  • 1. Developing a framework for the implementation of recommendations for lifestyle factors for people with RMDs across Europe: assessment of current materials and implementation needs.
    Rodríguez-Carrio J; Cavalli G; Gwinnutt J; Wieczorek M; Guillemin F; Verstappen SMM
    RMD Open; 2023 Aug; 9(3):. PubMed ID: 37652556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levelling the playing field of RMD research across Europe to address patients' needs: the emerging EULAR Research Centre.
    Reuter K; Haupt C; Molto A; Cope A; van Vollenhoven RF; Elewaut D; Lories R; McInnes IB
    RMD Open; 2022 Jun; 8(2):. PubMed ID: 35714997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of diet on the outcomes of rheumatic and musculoskeletal diseases (RMDs): systematic review and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs.
    Gwinnutt JM; Wieczorek M; Rodríguez-Carrio J; Balanescu A; Bischoff-Ferrari HA; Boonen A; Cavalli G; de Souza S; de Thurah A; Dorner TE; Moe RH; Putrik P; Silva-Fernández L; Stamm T; Walker-Bone K; Welling J; Zlatković-Švenda M; Guillemin F; Verstappen SMM
    RMD Open; 2022 Jun; 8(2):. PubMed ID: 35654458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2021 EULAR recommendations regarding lifestyle behaviours and work participation to prevent progression of rheumatic and musculoskeletal diseases.
    Gwinnutt JM; Wieczorek M; Balanescu A; Bischoff-Ferrari HA; Boonen A; Cavalli G; de Souza S; de Thurah A; Dorner TE; Moe RH; Putrik P; Rodríguez-Carrio J; Silva-Fernández L; Stamm T; Walker-Bone K; Welling J; Zlatković-Švenda MI; Guillemin F; Verstappen SMM
    Ann Rheum Dis; 2023 Jan; 82(1):48-56. PubMed ID: 35260387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of physical exercise and body weight on disease-specific outcomes of people with rheumatic and musculoskeletal diseases (RMDs): systematic reviews and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs.
    Gwinnutt JM; Wieczorek M; Cavalli G; Balanescu A; Bischoff-Ferrari HA; Boonen A; de Souza S; de Thurah A; Dorner TE; Moe RH; Putrik P; Rodríguez-Carrio J; Silva-Fernández L; Stamm T; Walker-Bone K; Welling J; Zlatković-Švenda MI; Guillemin F; Verstappen SMM
    RMD Open; 2022 Mar; 8(1):. PubMed ID: 35361692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smoking, alcohol consumption and disease-specific outcomes in rheumatic and musculoskeletal diseases (RMDs): systematic reviews informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs.
    Wieczorek M; Gwinnutt JM; Ransay-Colle M; Balanescu A; Bischoff-Ferrari H; Boonen A; Cavalli G; de Souza S; de Thurah A; Dorner TE; Moe RH; Putrik P; Rodríguez-Carrio J; Silva-Fernández L; Stamm TA; Walker-Bone K; Welling J; Zlatkovic-Svenda M; Verstappen SM; Guillemin F
    RMD Open; 2022 Mar; 8(1):. PubMed ID: 35351808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of impact of the COVID-19 pandemic from the perspective of patients with rheumatic and musculoskeletal diseases in Europe: results from the REUMAVID study (phase 1).
    Garrido-Cumbrera M; Marzo-Ortega H; Christen L; Plazuelo-Ramos P; Webb D; Jacklin C; Irwin S; Grange L; Makri S; Frazão Mateus E; Mingolla S; Antonopoulou K; Sanz-Gómez S; Correa-Fernández J; Carmona L; Navarro-Compán V
    RMD Open; 2021 Apr; 7(1):. PubMed ID: 33827969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barriers and facilitators for physical activity in rheumatic and musculoskeletal disease: a European-based survey.
    Metsios GS; Fenton SAM; Tzika K; Moe RH; Fragoulis GE; Vlieland TPMV; Nikiphorou E; Van den Ende CHM; Fatouros I; van der Esch M; Niedermann K; Stavropoulos-Kalinoglou A; van Zanten JJCSV; Brodin N; O'Brien CM; Koutedakis Y; Kennedy N; Swinnen TW; Bostrom C; Kitas GD;
    Clin Rheumatol; 2023 Jul; 42(7):1897-1902. PubMed ID: 36877304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EULAR points to consider for the use of imaging to guide interventional procedures in patients with rheumatic and musculoskeletal diseases (RMDs).
    Dejaco C; Machado PM; Carubbi F; Bosch P; Terslev L; Tamborrini G; Sconfienza LM; Scirè CA; Ruetten S; van Rompay J; Proft F; Pitzalis C; Obradov M; Moe RH; Mascarenhas VV; Malattia C; Klauser AS; Kent A; Jans L; Hartung W; Hammer HB; Duftner C; Balint PV; Alunno A; Baraliakos X
    Ann Rheum Dis; 2022 Jun; 81(6):760-767. PubMed ID: 34893469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The global challenges and opportunities in the practice of rheumatology: white paper by the World Forum on Rheumatic and Musculoskeletal Diseases.
    Al Maini M; Adelowo F; Al Saleh J; Al Weshahi Y; Burmester GR; Cutolo M; Flood J; March L; McDonald-Blumer H; Pile K; Pineda C; Thorne C; Kvien TK
    Clin Rheumatol; 2015 May; 34(5):819-29. PubMed ID: 25501633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common Language Description of the Term Rheumatic and Musculoskeletal Diseases (RMDs) for Use in Communication With the Lay Public, Healthcare Providers, and Other Stakeholders Endorsed by the European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR).
    van der Heijde D; Daikh DI; Betteridge N; Burmester GR; Hassett AL; Matteson EL; van Vollenhoven R; Lakhanpal S
    Arthritis Rheumatol; 2018 Jun; 70(6):826-831. PubMed ID: 29532625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of recommendations in rheumatic and musculoskeletal diseases: considerations for development and uptake.
    Loza E; Carmona L; Woolf A; Fautrel B; Courvoisier DS; Verstappen S; Aarrestad Provan S; Boonen A; Vliet Vlieland T; Marchiori F; Jasinski T; Van der Elst K; Ndosi M; Dziedzic K; Carrasco JM
    Ann Rheum Dis; 2022 Oct; 81(10):1344-1347. PubMed ID: 35961760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Needs, Experiences, and Views of People With Rheumatic and Musculoskeletal Diseases on Self-Management Mobile Health Apps: Mixed Methods Study.
    Najm A; Lempp H; Gossec L; Berenbaum F; Nikiphorou E
    JMIR Mhealth Uhealth; 2020 Apr; 8(4):e14351. PubMed ID: 32310151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of SARS-CoV-2 infection among children and young people with pre-existing rheumatic and musculoskeletal diseases.
    Kearsley-Fleet L; Chang ML; Lawson-Tovey S; Costello R; Fingerhutová Š; Švestková N; Belot A; Aeschlimann FA; Melki I; Koné-Paut I; Eulert S; Kallinich T; Berkun Y; Uziel Y; Raffeiner B; Oliveira Ramos F; Clemente D; Dackhammar C; Wulffraat NM; Waite H; Strangfeld A; Mateus EF; Machado PM; ; ; Natter M; Hyrich KL
    Ann Rheum Dis; 2022 Jul; 81(7):998-1005. PubMed ID: 35338032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current status of use of big data and artificial intelligence in RMDs: a systematic literature review informing EULAR recommendations.
    Kedra J; Radstake T; Pandit A; Baraliakos X; Berenbaum F; Finckh A; Fautrel B; Stamm TA; Gomez-Cabrero D; Pristipino C; Choquet R; Servy H; Stones S; Burmester G; Gossec L
    RMD Open; 2019; 5(2):e001004. PubMed ID: 31413871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protocol for a systematic literature review of smartphone apps to support the self-management of rheumatic and musculoskeletal diseases: development strategies, theoretical underpinnings and barriers to engagement.
    Barnett R; Clarke C; Sengupta R; Rouse PC
    Syst Rev; 2023 Jul; 12(1):129. PubMed ID: 37516896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Message from the new EULAR President and Steering Group.
    Iagnocco A; Aletaha D; Baraliakos X; McInnes IB
    Ann Rheum Dis; 2021 Oct; 80(10):1266-1267. PubMed ID: 34446430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EULAR points to consider for the development, evaluation and implementation of mobile health applications aiding self-management in people living with rheumatic and musculoskeletal diseases.
    Najm A; Nikiphorou E; Kostine M; Richez C; Pauling JD; Finckh A; Ritschl V; Prior Y; Balážová P; Stones S; Szekanecz Z; Iagnocco A; Ramiro S; Sivera F; Dougados M; Carmona L; Burmester G; Wiek D; Gossec L; Berenbaum F
    RMD Open; 2019; 5(2):e001014. PubMed ID: 31565245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2021 EULAR points to consider to support people with rheumatic and musculoskeletal diseases to participate in healthy and sustainable paid work.
    Boonen A; Webers C; Butink M; Barten B; Betteridge N; Black DC; Bremander A; Boteva B; Brzezińska O; Chauhan L; Copsey S; Guimarães V; Gignac M; Glaysher J; Green F; Hoving JL; Marques ML; Smucrova H; Stamm TA; Wiek D; Wilkie R; Woolf AD; Burmester GR; Bijlsma JW; Verstappen SMM
    Ann Rheum Dis; 2023 Jan; 82(1):57-64. PubMed ID: 36109139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 vaccine safety in adolescents with inflammatory rheumatic and musculoskeletal diseases and adults with juvenile idiopathic arthritis: data from the EULAR COVAX physician-reported registry.
    Lawson-Tovey S; Machado PM; Strangfeld A; Mateus E; Gossec L; Carmona L; Raffeiner B; Bulina I; Clemente D; Zepa J; Rodrigues AM; Mariette X; Hyrich KL;
    RMD Open; 2022 Jul; 8(2):. PubMed ID: 35908834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.